Ken Walsh, MSc, joined Lifescience Dynamics in 2021 as Senior Vice President and Global Head of Market Access, Pricing and Reimbursement. Ken came with over 20 years of experience across the Lifescience industry, with a deep focus on global pricing and market access strategy.

Previously, Ken worked at Navigant for 4 years, where he co-led the global market access practice. In his industry roles, Ken also worked as head of pricing in GSK’s emerging market division, and as global head of pricing and market access for Sandoz Biosimilars and Oncology injectables business unit.

Ken graduated with a MA (Hons) in Economics from Heriot-Watt University and an MSc in Finance from Cass Business School, London.

Ken is based in our London office.